The U.S. House of Representatives unanimously passed two bills yesterday, H.R. 1520 (Purple Book Continuity Act of 2019) and H.R. 1503 (Orange Book Transparency Act of 2019). The Purple Book Continuity Act of 2019 would require the Purple Book to publish lists of patents associated with approved biological products, but…